版本:
中国

BRIEF-Biostage reports Q1 loss per share $0.14

May 11 Biostage Inc:

* Biostage reports 2017 first quarter financial results and provides business update

* Q1 loss per share $0.14

* Biostage Inc - remains on track to file ind with fda for esophageal implant program in Q3 2017

* Biostage Inc - believes it has sufficient cash on hand to fund operations through Q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐